UDP-glucuronosyltransferase 1-1 — Drug Target

All drugs that target UDP-glucuronosyltransferase 1-1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Protease Inhibitor

Marketed (1)

• Reyataz · Bristol-Myers Squibb · Protease Inhibitor · Immunology
  Reyataz works by blocking the protease enzyme, which is essential for the replication of HIV.